New research from the University of Birmingham has shown that progesterone supplements in the first trimester of pregnancy do not improve outcomes in women with a history of unexplained recurrent miscarriages.
Nov 25, 2015
0
46
(HealthDay)—Hidradenoma papilliferum in association with pregnancy has been illustrated in a case report published online Aug. 12 in the Journal of Cutaneous Pathology.
Aug 23, 2015
0
12
(HealthDay)—Biomarkers can be used to guide decisions on systemic therapy for women with metastatic breast cancer, according to the American Society of Clinical Oncology Clinical Practice Guideline published online July ...
Jul 21, 2015
0
11
A special technique where breast cancer cells are "rescued" for research has been developed at the University of Adelaide. Coupled with advanced scientific technologies pioneered by Cambridge University this has provided ...
Jul 8, 2015
0
38
Researchers have found that smoking may increase the risk of dying early in premenopausal women with breast cancer.
Jun 24, 2015
0
27
Although traditionally understood to induce death in cancer cells, researchers at The University of Texas MD Anderson Cancer Center have discovered that the DAPK1 protein is actually essential for growth in breast and other ...
Jun 15, 2015
0
165
Menopausal hormone therapy (MHT) given to recently postmenopausal women in the US for up to four years does not improve cognition, but may have some positive benefits for some mood symptoms, according to a study published ...
Jun 2, 2015
0
10
(HealthDay)—Exogenous progesterone seems to increase nuchal translucency (NT), according to a study published in the March issue of the American Journal of Obstetrics & Gynecology.
Mar 31, 2015
0
3
Impending fatherhood can lower two hormones—testosterone and estradiol—for men, even before their babies are born, a new University of Michigan study found.
Dec 15, 2014
1
0
Treatment of acute traumatic brain injury with the hormone progesterone provides no significant benefit to patients when compared with placebo, a NIH-funded phase III clinical trial has concluded.
Dec 10, 2014
0
0
